Fiocruz Will Start Tests with 1st Brazilian Vaccine Made with Messenger RNA
9 Articles
9 Articles
Brazil will test in humans first mRNA vaccine with 100% national technology Bernardo Portella Brazil will test in humans, for the first time, a vaccine developed with messenger RNA technology (mRNA). The immunizer created by Fiocruz against Covid-19 has just received authorization from the National Health Surveillance Agency (Anvisa) to advance the clinical study. Researchers explain that the advance goes beyond the immunizer and changes the sce…
Immunizing developed by Fiocruz was endorsed by Anvisa and must begin to be tested in humans in the first quarter of 2027 The post Fiocruz bets on new vaccine against Covid-19 that can change the future of immunization in Brazil; see when tests start appeared first in ND More
Metrópoles
Immunizing against Covid-19 will be tested as reinforcement after authorization of Anvisa and can open the way for new vaccines and therapies in the country
Immunizing Fiocruz against Covid-19 receives support from Anvisa and opens the way for use of the Brazilian platform in research against cancer, dengue, malaria and Chagas disease
Brazil advances in the development of its own technologies for the production of vaccines. The Ministry of Health announced on Wednesday (2) that Fiocruz will initiate clinical trials in humans of a vaccine against Covid-19 developed entirely in the country with messenger RNA technology (mRNA).Immunizer is the result of a partnership between Fiocruz and the Institute of Technology in Immunobiologicals (Bio-Manguinhos).Before reaching the clinica…
National vaccine development may create immunizations against Covid-19, cancer and other diseases; see next steps
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
